Pfizer: all 4,072 studies
Page 24 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid CardiomyopathyCompletedNCT04801329
- PF-07284892 in Participants With Advanced Solid TumorsTerminatedNCT04800822Phase 1
- First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.Active, not recruitingNCT04767594
- Post Marketing Surveillance (PMS) Study of Cresemba in Korea.CompletedNCT04744454
- Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment OptionsNo longer availableNCT04724421
- Korea Post Marketing Surveillance (PMS) Study of VizimproCompletedNCT04721106
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
- A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaActive, not recruitingNCT04657991Phase 3
- Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel SyndromeTerminatedNCT04655599Phase 1
- Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy ParticipantsCompletedNCT04655040Phase 1
- Swedish Ibrance Registries Insights (SIRI)CompletedNCT04654208
- PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTSCompletedNCT04634565Phase 1
- Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult ParticipantsCompletedNCT04627532Phase 1
- Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative ColitisActive, not recruitingNCT04624230Phase 3
- Anticoagulation in Patients With Venous Thromboembolism and CancerCompletedNCT04618913
- STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITYCompletedNCT04616339Phase 1
- Brentuximab Vedotin With Pembrolizumab in Metastatic Solid TumorsCompletedNCT04609566Phase 2
- A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male ParticipantsCompletedNCT04591262Phase 1
- Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release FormulationsCompletedNCT04580797Phase 1
- A Study to Determine the Bioequivalence of Two Doses of TafamidisCompletedNCT04575116Phase 1
- Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNo longer availableNCT04564755
- Axitinib Therapy Management StudyWithdrawnNCT04555603
- PF-07104091 as a Single Agent and in Combination TherapyActive, not recruitingNCT04553133Phase 2
- Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed ConditionCompletedNCT04549480Phase 1
- Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of ReciferceptCompletedNCT04543344Phase 1
- TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.CompletedNCT04498481
- Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961CompletedNCT04495140Phase 1
- BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURGCompletedNCT04478357Phase 1
- Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated TriglyceridesCompletedNCT04459767Phase 1
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation AdministerCompletedNCT04452838Phase 1
- Tofacitinib in Adult Patients With Moderate to Severe Ulcerative ColitisCompletedNCT04424303
- Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care TherapyWithdrawnNCT04412252Phase 2
- Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46CompletedNCT04410809Phase 1
- PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release FormulationCompletedNCT04403776Phase 1
- Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.CompletedNCT04390776Phase 1
- Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult ParticipantsCompletedNCT04388878Phase 1
- A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.CompletedNCT04355845Phase 1
- A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) FormulationsCompletedNCT04338711Phase 1
- Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In SwedenCompletedNCT04338204
- Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSVWithdrawnNCT04267822Phase 2
- Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive SteroidsCompletedNCT04267250Phase 1
- Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600CompletedNCT04266509Phase 1
- Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell DiseaseCompletedNCT04255875Phase 1
- A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular DystrophyTerminatedNCT04254172
- A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerTerminatedNCT04254107Phase 1
- A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin PharmacokineticsCompletedNCT04253353Phase 1
- Acute Myeloid Leukemia Real World Treatment PatternsWithdrawnNCT04230564
- A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesActive, not recruitingNCT04227847Phase 1
- Treatment Protocol of Tucatinib With Capecitabine and Trastuzumab in Patients With Unresectable Previously Treated HER2+ Breast CancerApproved for marketingNCT04220203
- A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative ColitisWithdrawnNCT04209556Phase 2
- The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based StudyWithdrawnNCT04198844
- Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In PortugalWithdrawnNCT04156672
- Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.TerminatedNCT04152018Phase 1
- Study of Single Ascending Doses of PF-07081532 in Healthy Adult ParticipantsCompletedNCT04148209Phase 1
- A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy ParticipantsCompletedNCT04135560Phase 1
- A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female ParticipantsCompletedNCT04134715Phase 1
- A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERSWithdrawnNCT04126044Phase 1
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy ParticipantsCompletedNCT04124653Phase 1
- A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.CompletedNCT04111614Phase 1
- Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy ParticipantsCompletedNCT04099563Phase 1
- A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy ParticipantsCompletedNCT04092595Phase 1
- A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy ParticipantsCompletedNCT04090047Phase 1
- Pharmacokinetics and Safety of RV521 FormulationsCompletedNCT04065698Phase 1
- Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial FormulationCompletedNCT04065633Phase 1
- Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult ParticipantsCompletedNCT04044053Phase 1
- A Study of SGN-CD228A in Advanced Solid TumorsTerminatedNCT04042480Phase 1
- Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive SteroidsCompletedNCT04018274Phase 1
- Bioavailability Study of PF-06651600 Formulations in Healthy ParticipantsCompletedNCT04004663Phase 1
- Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy ParticipantsCompletedNCT03978143Phase 1
- Singe Dose Study of PF- 06946860 in Healthy Adult Japanese ParticipantsCompletedNCT03974776Phase 1
- Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy ParticipantsCompletedNCT03961997Phase 1
- A Safety Study of SGN-CD47M in Patients With Solid TumorsTerminatedNCT03957096Phase 1
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03950232Phase 3
- Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment OptionsNo longer availableNCT03943615
- A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy ParticipantsCompletedNCT03937258Phase 1
- An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of MigraineNo longer availableNCT03934086
- Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600.CompletedNCT03929510Phase 1
- THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTSCompletedNCT03916406Phase 1
- PF-06651600 Taste Study.CompletedNCT03916393Phase 1
- Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy ParticipantsCompletedNCT03916250Phase 1
- A Safety, Tolerability, and Pharmacokinetic Study of Tucatinib in Healthy Japanese and Caucasian SubjectsCompletedNCT03914755Phase 1
- Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant MelanomaTerminatedNCT03878719Phase 1
- OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTSCompletedNCT03871439Phase 1
- Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who SmokeCompletedNCT03860506Phase 1
- Safety and Efficacy of LorbrenaCompletedNCT03844464
- A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTSCompletedNCT03827668Phase 1
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on MetforminCompletedNCT03826602Phase 1
- Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy ParticipantsCompletedNCT03821493Phase 1
- Diflucan Bioequivalence Study For Transferring The ManufactureCompletedNCT03821480Phase 1
- A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) TreatmentWithdrawnNCT03812835
- Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy ParticipantsCompletedNCT03806101Phase 1
- A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement SurgeryWithdrawnNCT03804125
- Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet TabletsCompletedNCT03803371Phase 4
- A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed ConditionsWithdrawnNCT03794154Phase 4
- Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical CancerTerminatedNCT03786081Phase 1/2
- A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult ParticipantsCompletedNCT03782662Phase 1
- Effects of Tucatinib on Cardiac Repolarization in Healthy ParticipantsCompletedNCT03777761Phase 1
- Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male SubjectsCompletedNCT03770039Phase 1
- Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different FormulationsCompletedNCT03765554Phase 1